• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    S

    Sentara Virginia Beach General Hospital

    35论文总数
    920引用总数

    Sentara Healthcare is a not-for-profit healthcare organization serving Virginia and northeastern North Carolina. It is based in Norfolk, Virginia and offers services in 12 acute care hospitals, with 3,739 beds, 853,000 members in its health plan, 10 nursing centers, and three assisted living facilities across the two states. Sentara Healthcare operates its own managed-care plan in Optima Health which covers 450,000 subscribers in the region. It also operates four medical groups.

    论文量&引用量时间轴

    机构学者

    论文(35)

    年份
    起
    –
    止
    排序
    1Multivariable Statistical Analysis Techniques to Identify Subpopulations in Method Comparisons Studies. A Practical Example Comparing with Two Methods for Erythrocytes Sedimentation Rate.
    Kathryn Golab, Wazhan Tang, Ryan Montgomer, Tewodros Mola, Dina Radi,Valerio Genta

    Abstract Background Erythrocytes sedimentation rate methods comparisons employing patient specimens may be affected by subpopulations of patient’s specimens characterized by different rates. While these subpopulations may be detected with multiple comparisons employing univariate data analysis techniques, their detection with multivariable data analysis techniques is preferable for efficiency and avoidance of type one error. We present a practical example for the erythrocytes sedimentation rate performed with two methods employing patient’s blood specimens. Methods Two-hundred-forty-seven individual patient’s blood specimens, collected by venipuncture in lavender tubes (Becton-Dickinson), were assayed with miniiSED® (Alcor Scientific, new method, SVBGH, SBLH), iSEDElite® (Alcor scientific, new method, SCPH) and Excyte® (EliTech Group, current method) in parallel and within fifteen minutes in three Sentara Laboratories (SBLH: 59 specimens, SCPH:68 specimens, SVBGH:120 specimens). The data were transferred manually from the instrument printout to Minitab® (Version 22, Minitab Inc.) statistical software. Demographics and the values for HCT and MCV were recorded for each patient. HCT and MCV values were coded as N for normal, L for lower and H for higher, according to their value in relation to the reference range. The data were then analyzed with univariate ordinary least squares (OLS), orthogonal least squares (OrthLS), weighted polynomial least squares (WPLS) statistical techniques, their diagnostics and graphic representations. Results The univariate OLS (Y=7.6+0.8X, Sy/x=17.5) and OrtLS (Y=2.4+0.97X, Sy/x=13) showed similar regression equations. The plots of the standardized residuals by the fitted value showed a fan-shaped increase in variance for increasing RSR values. To investigate whether the increase in variance was due to patient’s subgroups defined by Location, HCT and MCV coded values, the data were analyzed with WPLS model. The ANOVA table of the WPLS showed probabilistically significant differences for subgroups defined by the HCT (F=16.8, P<0.0001), MCV (F=7.0,P=0.024) values and Location (F=3.8, P=0.024). These results indicated that HCT and MCV were more important predictors than Location and were corroborated by forward and backward selection techniques. The plots of the standardized deleted residuals showed a quasi-normal distribution with a few outliers (Standardized deleted residual>|3|) and one influential observation (Hi=0.7). The plot of the miniiSED values by the Excyte values showed four distinct regression lines for LHCT-LMCV, LHCT-NMCV , LHCT-HMCV which fanned away from the NHCT-NMCV regression line. This explained the wide distribution of the observations for increasing ESR values. Conclusion The WPLS model identified the effect of abnormal HCT and MCV values on the ESR rate. This was clearly illustrated by graphic representation of the regression lines for the normal and abnormal combinations of HCT and MCV. Consequently, only the subpopulation characterized by normal HCT and MCV values may have interchangeable ESR reference values. However, additional studies with a larger patient population may be required to define the ESR reference values for the subpopulations with abnormal HCT and MCV. In conclusion, the multivariable regression analysis model technique offered an immediate, efficient and effective method to identify subpopulations in the patient population used for this comparison study. Finally, the availability of univariate and multivariable statistical software such as Minitab was critical.

    2026CLINICAL CHEMISTRY(2026)
    引用
    AI阅读
    加入学术空间
    2Anesthetic Outcomes: Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgery Patients Who Had General Anesthesia with an Enhanced Recovery after Surgery (ERAS) Technique
    Victoria Goode, Seon Hee Kang, Morgan Hornsby, Rica Reuyan, Samantha Doughton, Devon Williams, Courtney Cripps, Karen Richendollar, Wendy Pelton, Darian Harris, Angela Toepp

    PURPOSE:Postoperative nausea and vomiting (PONV) is a common occurrence that leads to patient discomfort and prolonged length of stay. The average rate of PONV is approximately 30% in the general population and can be as high as 70% to 80% in those at high risk. Enhanced recovery after surgery (ERAS) protocols have been created from analysis of current evidence-based research aimed to decrease postoperative complications and improve patient outcomes following surgical interventions. DESIGN:This retrospective pre-experimental cohort study used convenience sampling of 1,200 past surgical patients to determine the trend of PONV rates in females who underwent laparoscopic gynecological surgery from 2018 to 2024, and to examine whether there was a difference in PONV rates between those who received general anesthesia utilizing ERAS protocols and those who did not during the designated time period. METHODS:Compliance with antiemetic ERAS protocols was recorded and defined by the administration of three or more antiemetics, and noncompliance was defined as fewer than three. The primary outcome, the presence of PONV, was assessed by the administration of rescue antiemetics in the postanesthesia care unit (PACU). Additional outcomes included PACU length of stay and provider compliance with the ERAS protocols. FINDINGS:The findings reflect those who received a general anesthetic before the introduction of the ERAS protocol through its early and most current use. During this time period, 1,200 patients underwent laparoscopic gynecologic surgery with general anesthesia. The study divided participants into pre-ERAS (2018 to 2019), early-ERAS (2020 to 2022), and current-ERAS (2023 to 2024) groups. The result of this study found a statistically significant decrease in ERAS compliance (P = .004), with a concurrent increase in PONV rates (P < .001). In patients who reported PONV, PACU length of stay increased from a mean of 92.75 (44.8) minutes in 2018 to 2019 to 130.7 (47.8) minutes in 2023 to 2024 (P = .001). Our study discovered that there was an overall decrease in compliance rates with antiemetic prophylactic administration throughout all phases of the perioperative period. CONCLUSIONS:PONV is a key postoperative issue affecting patient comfort, recovery, and health care resources. Our findings emphasize the importance of comprehensive ERAS adherence beyond pharmacologic prophylaxis and call for further research to refine protocols based on patient outcomes, risk factors, and evolving pharmacology.

    2026Journal of perianesthesia nursing official journal of the American Society of PeriAnesthesia Nurses(2026)
    引用
    AI阅读
    加入学术空间
    3Polynomial Regression Analysis Techniques to Evaluate the Interchangeability of I-Stat® Cartridges and the Laboratory Method for Patient Blood Glucose Values. A Practical Example with Data Collect for Twelve Months
    Valerio Genta, Brad Poore, Dina Radi, Sara Shumate, Carl Alston, David Mitchell

    Abstract Background In emergency situations, i-STAT®1 cartridges offer rapid results at the patient bedside allowing both prompt medical decisions and interventions. In non-emergency situations, patient blood assays are performed with the Laboratory Method. To evaluate and monitor the interchangeability of i-STAT and the laboratory method for blood glucose values we compared the two methods with paired data obtained in one year using polynomial regression analysis techniques. Methods The patient blood glucose values obtained with i-STAT Chem8® or CG8® cartridges and those obtained with the laboratory method (LM) (Two cobas 6000®, Roche Diagnostics) within thirty minutes on the same patient, were collected electronically and transferred to Minitab® (Version 22, Minitab Inc) statistical software. Three thousand eight hundred seventy four paired observations obtained for twelve months were analyzed with orthogonal, ordinary (OLS), weighted polynomial (WPLS) least squares regression analysis, locally weighted scatter plot smoother (Lowess) statistical techniques, their diagnostics and graphic representations. The 99% confidence (CI) and 99% prediction (PI) intervals were obtained for the WPLS. The criterion target value +/- 6 mg/dL, or 8%, greater was used for acceptability of absolute and relative differences respectively. Results For blood glucose values between 30 and 600 mg/dL the orthogonal (i-STAT=1.3+1.006 LM) and the OLS (i-STAT=1.6+1.004 LM) regression equations were very similar. For both methods the standardized residuals by the fitted value showed increasing variance in Y for increasing values in X. Consequently, for additional analysis the WPLS was employed. WPLS equation: i-STAT=1+1.005 LM. The ANOVA table showed probabilistically significant differences between month regression lines (P<0.0001); this was due to very small Sy/x=0.4mg/dL. The lack-of-fit test showed probabilistically significant lack-of-fit (P<0.0001); this was due to very small pure error=0.1 mg/dL. The standardized deleted residuals (SDR) plots showed quasi-normal distribution, equality of variance and no unnatural distribution by observation order. The plot of SDR by the fitted value showed quasi-linear and similar lowess by month. The SDR plot by the leverage (Hi) showed a few possible outliers (SDR>|3|) and no influential observations (Hi<0.5). The CI and PI for laboratory method values of 50 mg/dL (Fit=52, CI=51-52,PI=45-58), 250 mg/dL (Fit=253, CI=252-253, PI=237-268) and 550 mg/dL (Fit=554, CI=552-555, PI-530-578) clearly indicated that the differences between methods would be within the total allowable error. This was corroborated by the plot of the relative differences by the month which showed that few relative differences exceeded the total error limits (69/3874=1.8%). Conclusions The WPLS model showed that for a period of twelve months the relationship between paired patient blood glucose values obtained with i-STAT cartridges and the cobas 6000 method, was quasi-linear with few differences exceeding the criterion target value +/- 6mg/dl, greater. Additionally, the 99% PI indicated that this relationship would be reliably anticipated if the same testing conditions were maintained. The automatic updating function of Minitab software allowed prompt detection of outliers, investigation and intervention by the Point of Care MLS. This study showed that the availability of multivariable statistical software, such as Minitab, was essential for the fast analysis of the data and their actionability.

    2026CLINICAL CHEMISTRY(2026)
    引用
    AI阅读
    加入学术空间
    4Evaluation of Bivalirudin-Based Anticoagulation for Extracorporeal Membrane Oxygenation, Including Patients with COVID-19.
    Miranda Raguindin, Casey Bardsley, Chelsea Bast,David Sugrue, Hasan Kazmi,Ashley Milkovits

    Background: Although unfractionated heparin (UFH) has traditionally been used for anticoagulation during extracorporeal membrane oxygenation (ECMO), bivalirudin may be preferred due to fewer complications. A prior medication use evaluation of ECMO patients who received bivalirudin resulted in dosing updates for our pharmacist-directed bivalirudin protocol. This study intended to evaluate the efficacy and safety of bivalirudin for anticoagulation during ECMO support post-protocol initiation. Methods: This was a retrospective, single-center, pre-post study. Adult patients requiring ECMO support for at least 24 h and who received bivalirudin between January 1, 2015 to July 31, 2018 (pre-group) and May 1, 2019 to June 30, 2021 (post-group) were included. Results: There were 38 patients in the pre- and 35 patients in the post-group. The primary outcome, median time to two consecutive activated partial thromboplastin times (aPTTs) within therapeutic range for the initial goal range, was 8.9 h in the pre- and 14.2 h in the post-group (p = 0.517). In a subgroup analysis of the post-group, the primary outcome was higher in patients with COVID-19 (26.5 vs. 8.6 h, p = 0.018). The median number of dose adjustments to achieve goal aPTT was higher in COVID-19 patients (4 vs. 2, p = 0.017). Conclusion: These results suggest that a standardized pharmacist-directed protocol for bivalirudin in ECMO achieves timely therapeutic anticoagulation levels. Patients with COVID-19 trended toward longer times to two consecutive therapeutic aPTTs. Further studies are needed to evaluate dosing strategies in patients with and without COVID-19.

    2026The journal of extra-corporeal technology(2026)
    引用
    AI阅读
    加入学术空间
    5A-378 Acceptance and Harmonization of I-Stat Cartridges. A Practical Example with G3+ Cartridges
    Valerio Genta, Sara Shumate, Dina Radi, Carl Aston

    i-STAT cartridges offer a rich menu of overlapping assays performed at the point of care which optimizes a rapid, flexible and interchangeable use for patient care. Acceptance and harmonization studies insure interchangeability and reliability of cartridges. We are presenting a practical example of the use of multivariate statistical techniques for acceptance and harmonization studies performed for i-STAT G3+ cartridges in sixteen facilities of Sentara Healthcare. i-STAT™ cartridges: G3+®, CG4+® and CG8+® (Abbott Laboratories). Quality Control material Cue See® VeriSTAT QC Level 1 and Level 3. AMR material: Cue See® VeriSTAT LVM (Eurotrol), 5 Levels. Patient specimens: 212 (Arterial:82, Cord arterial:14, Cord venous:10, Venous:106). The two levels of QC material were assayed five times per facility. The five levels of AMR material were assayed in triplicate for each location of each facility. The data were collected and transferred electronically to Minitab® (Version 22, Minitab Inc.) and analyzed with multivariable statistical techniques for equality of means, variances and regression lines between facilities. The patient specimens were assayed in parallel and within fifteen minutes with CG3+ and, as references, CG4+ and CG8+ cartridges. Criterion for acceptance of absolute differences obtained between values obtained with CG3+ and the reference cartridges: target value +/- 0.04 pH Units. The multiple comparisons between facilities with ANOVA showed probabilistically significant mean differences between facilities (Level 1 and Level 3:P <0.001) ; however, these differences were due to very small MSE (Level 1=0.000039, level3=0.000013) which was not significant for either QC or clinical practices. The parallel box plots for each level of control clearly showed that the differences were within half of the total allowable error (0.04 pH Units).The weighted polynomial regression model detected probabilistically significant differences between AMR regression lines by facility, however this was due to very small MSE (=0.000009 pH Units) which was not significant for either QC or clinical practices. The normal probability of the standardized deleted residuals for the regression model showed a quasi-normal distribution, and the plot of the standardized deleted residuals by the fitted value showed a very similar, quasi-linear locally weighted scatterplot smoother (lowess) for each facility. The absolute differences between the assayed and the reference values was within target value +/- 0.04 pH units for all the facilities. The orthogonal regression model showed that the patient values obtained with G3+ cartridges had a quasi-linear relationship with the values obtained with the reference cartridges. Additionally, the absolute differences between the assayed and the reference values was within target value +/- 0.04 pH units for all the facilities. The performance of G3+ cartridges was acceptable and interchangeable with that of CG4+ and CG8+ cartridges. This practical example showed that the use of multivariate statistical techniques and their graphic representations allowed immediate, parsimonious evaluation of studies for the acceptance and harmonization of i-STAT G3+ cartridges performed in several facilities of a Health system. For these studies the electronic transfer of data and the analysis with statistical software such as Minitab was critical.

    2025Clinical Chemistry(2025)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 35 篇论文

    合作机构(25)

    威廉·比蒙医院合作论文 10
    杜克大学合作论文 8
    Washington Adventist Hospital,Adventist HealthCare合作论文 7
    Ospedali Riuniti di Ancona合作论文 6
    哥伦比亚大学合作论文 4
    Sentara Healthcare合作论文 4
    奥多明尼昂大学合作论文 3
    安舒茨医学中心合作论文 2
    Doylestown Hospital合作论文 2
    Moses H Cone Memorial Hospital,Cone Health合作论文 2

    机构统计